Zhao Hui, a board member of Anhui Anke Biotechnology (300009.SZ), intends to reduce his holdings by no more than 950,000 shares of the company.

Anke Biotechnology (300009.SZ) announced that Zhao Hui, a director and senior executive who holds 10.0325 million shares of the company (accounting for 0.60% of the total share capital), plans to reduce his holdings by 950,000 shares (accounting for 0.06% of the total share capital) through centralized bidding or block trading within three months following the fifteenth trading day after the announcement date (i.e., from September 29, 2026, to December 28, 2026).